Risk factors
Elicio Therapeutics (ELTX) risk factors
Item 1A of every Elicio Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors90 risks13 new9 dropped28 reworded
Elicio Therapeutics faces new risks regarding trade tariffs, early-stage clinical execution, and patent exclusivity for ELI-002.
Filed Mar 12, 2026 - FY2024 10-K risk factors86 risks
The risk section is dominated by severe going concern warnings, heavy reliance on external capital, and lack of approved commercial products.
Filed Mar 31, 2025